Title:
ACT TEST CHIP
Document Type and Number:
WIPO Patent Application WO/2023/134167
Kind Code:
A1
Abstract:
An activated clotting time (ACT) test chip (1). The ACT test chip (1) comprises a chip body (101) and a chip housing (102); a front end of the chip body (101) is a chip test end (10101), and the chip body (101) is further provided with a chip sample feeding end (10102), the chip sample feeding end (10102) being distant from the chip test end (10101); the chip sample feeding end (10102) is arranged inside the chip housing (102); and a reaction reagent is provided inside the ACT test chip (1). A blood sample and the reaction reagent in the ACT test chip (1) are uniformly mixed, blood in the ACT test chip (1) gradually clots, an electrical signal in a reaction process is transmitted by means of an electrode, and the chip test end (10101) is connected to a blood coagulation analyzer to obtain an ACT test result; the ACT test result is displayed on a display screen of the blood coagulation analyzer, or the test result may be printed. The chip sample feeding end (10102) is disposed in the chip housing (102), and the chip housing (102) supports the ACT test chip (1). ACT testing can be performed, and the problem of conveniently taking the test is solved.
Inventors:
YANG SHEN (CN)
XU XINGSHANG (CN)
CHEN JEFFERY (CN)
WANG LONG (CN)
XU XINGSHANG (CN)
CHEN JEFFERY (CN)
WANG LONG (CN)
Application Number:
PCT/CN2022/112648
Publication Date:
July 20, 2023
Filing Date:
August 16, 2022
Export Citation:
Assignee:
LANSION BIOTECHNOLOGY CO LTD (CN)
International Classes:
G01N27/416; B01L3/00
Foreign References:
| CN114371209A | 2022-04-19 | |||
| CN209829010U | 2019-12-24 | |||
| CN215066329U | 2021-12-07 | |||
| CN110057890A | 2019-07-26 | |||
| CN108398470A | 2018-08-14 | |||
| CN106999931A | 2017-08-01 | |||
| US20170074893A1 | 2017-03-16 |
Attorney, Agent or Firm:
NANJING ZHENGLIAN INTELLECTUAL PROPERTY AGENCY CO., LTD. (CN)
Download PDF: